PEAK6 Investments’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.28M Sell
19,200
-43,500
-69% -$4M 0.01% 1426
2024
Q2
$5.04M Buy
62,700
+54,600
+674% +$4.99M 0.01% 837
2024
Q1
$747K Sell
8,100
-109,700
-93% -$10.5M ﹤0.01% 2141
2023
Q4
$12.4M Buy
117,800
+19,800
+20% +$2M 0.05% 388
2023
Q3
$10.6M Sell
98,000
-19,000
-16% -$2.1M 0.05% 366
2023
Q2
$12.6M Sell
117,000
-14,700
-11% -$1.65M 0.06% 285
2023
Q1
$16.4M Sell
131,700
-131,800
-50% -$18.1M 0.08% 229
2022
Q4
$39.6M Buy
263,500
+35,000
+15% +$5.39M 0.23% 66
2022
Q3
$30.8M Sell
228,500
-187,000
-45% -$28.6M 0.13% 125
2022
Q2
$57.1M Buy
415,500
+50,000
+14% +$7.64M 0.11% 149
2022
Q1
$62.3M Sell
365,500
-124,800
-25% -$21M 0.13% 136
2021
Q4
$126M Sell
490,300
-6,700
-1% -$1.83M 0.27% 54
2021
Q3
$136M Buy
497,000
+415,400
+509% +$132M 0.3% 42
2021
Q2
$18.3M Buy
81,600
+52,100
+177% +$9.83M 0.04% 399
2021
Q1
$3.22M Buy
+29,500
New +$3.13M 0.01% 1425

Other funds holding BNTX

PEAK6 Investments's BNTX Position: Q3 2024 in Review

PEAK6 Investments sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 17,750 shares — an estimated $1.63M sold.

PEAK6 Investments first reported a position in BNTX in Q1 2021 and held it in 12 quarters. The position peaked at $57.9M in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • PEAK6 Investments reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 17,750 BioNTech shares in Q3 2024, an estimated $1.63M.
  • PEAK6 Investments first reported a position in BioNTech in Q1 2021 and held it in 12 quarters.
  • PEAK6 Investments's BioNTech position peaked at $57.9M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.